{"id":228733,"title":"Notice to Stakeholders - Implementation of Establishment Licensing Requirements for Atypical Active Pharmaceutical Ingredients - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-19","captureTimestamp":"2025-04-19T00:17:23.558000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/notice-stakeholders-implementation-establishment-licensing-requirements-atypical-active-pharmaceutical-ingredients.html?wbdisable=false","snippet":"Notice to Stakeholders - Implementation of Establishment Licensing Requirements for Atypical Active Pharmaceutical Ingredients - Canada.ca Skip to main content Skip to \"About government\" Skip to section menu Language selection Français fr / Gouvernement du Canada Search Search…","rawSnapshotUrl":"/api/snapshots/raw/228733","browseUrl":"https://replay.healtharchive.ca/job-1/20250419001723/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/notice-stakeholders-implementation-establishment-licensing-requirements-atypical-active-pharmaceutical-ingredients.html?wbdisable=false#ha_snapshot=228733","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}